Psykey, Inc. (CEOS)

Market Cap	1.75M -76.1%
Revenue (ttm)	n/a
Net Income	-5.01M
EPS	-0.41
Shares Out	313.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	350,000
Average Volume	109,460
Open	0.0036
Previous Close	0.0026
Day's Range	0.0036 - 0.0056
52-Week Range	0.0006 - 0.0165
Beta	0.63
RSI	54.65
Earnings Date	n/a

About Psykey

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2002
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: CEOS